VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 10 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2012. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $5,000 | -58.3% | 50 | -28.6% | 0.00% | – |
| Q3 2015 | $12,000 | -33.3% | 70 | -12.5% | 0.00% | -100.0% |
| Q2 2015 | $18,000 | -25.0% | 80 | -35.0% | 0.00% | 0.0% |
| Q1 2015 | $24,000 | +4.3% | 123 | -24.5% | 0.00% | 0.0% |
| Q4 2014 | $23,000 | 0.0% | 163 | -8.4% | 0.00% | 0.0% |
| Q3 2014 | $23,000 | -17.9% | 178 | -20.5% | 0.00% | 0.0% |
| Q2 2014 | $28,000 | +12.0% | 224 | +18.5% | 0.00% | 0.0% |
| Q1 2014 | $25,000 | -99.4% | 189 | -99.6% | 0.00% | -98.9% |
| Q2 2013 | $4,418,000 | +37.0% | 51,325 | -4.3% | 0.09% | +39.7% |
| Q1 2013 | $3,225,000 | +3.2% | 53,625 | +2.6% | 0.06% | -1.6% |
| Q4 2012 | $3,125,000 | +5.3% | 52,285 | -2.6% | 0.06% | -5.9% |
| Q3 2012 | $2,968,000 | +26.0% | 53,685 | +2.1% | 0.07% | +13.3% |
| Q2 2012 | $2,355,000 | -7.9% | 52,585 | +10.4% | 0.06% | -6.2% |
| Q1 2012 | $2,557,000 | +10.6% | 47,635 | -3.7% | 0.06% | +6.7% |
| Q4 2011 | $2,311,000 | +21.4% | 49,485 | -3.5% | 0.06% | +9.1% |
| Q3 2011 | $1,903,000 | -30.7% | 51,275 | -3.0% | 0.06% | -19.1% |
| Q2 2011 | $2,748,000 | +0.9% | 52,880 | -3.3% | 0.07% | 0.0% |
| Q1 2011 | $2,723,000 | +67.8% | 54,675 | -4.7% | 0.07% | +58.1% |
| Q4 2010 | $1,623,000 | – | 57,385 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |